EN
NL
FR
ES
PT
Borrelia miyamotoi, a tick-borne bacterium, is gaining recognition as an emerging global pathogen, causing both specific and non-specific symptoms in infected individuals across various geographical locations.
The articles listed below provide valuable insights into this bacterium's nature, how it causes disease, and advancements in its detection and treatment.
1. Borrelia miyamotoi: An Emerging Tick-Borne Pathogen. Among infections identified in tick-borne diseases in the United States, Borrelia miyamotoi, from the relapsing fever group of borrelia, presents with non-specific febrile illness symptoms. It's effectively treated by antibiotic regimens similar to those for Lyme disease. Challenges in diagnosing B. miyamotoi infections are noted, with potential misdiagnoses due to its similarities with Lyme disease. The prevalence and geographic reach of B. miyamotoi are also discussed.
2. Borrelia miyamotoi—An Emerging Human Tick-Borne Pathogen in Europe. Borrelia miyamotoi, a spirochete bacterium, causes Borrelia miyamotoi disease (BMD), which has been reported across several continents. Variabilities in symptoms are found among different geographical strains of the disease. The study emphasizes the significance of BMD in public health, especially in Europe.
3. Borrelia miyamotoi Meningoencephalitis in an Immunocompetent Patient. A usually healthful patient suffered from Borrelia miyamotoi meningoencephalitis, a rare occurrence. Challenges in diagnosing culture-negative meningoencephalitis are discussed, with tick-borne illnesses identified as a chief, potentially treatable cause.
4. A Case of Tick-borne Disease with Yezo Virus and Borrelia miyamotoi Coinfection. This article highlights a patient with a coinfection of the recently recognized Yezo virus and Borrelia miyamotoi, both transmitted via tick bites. The case emphasizes the potential of Yezo virus to cause substantial illness in patients and its capacity to coexist with other tick-borne diseases.
